What is the risk of suicidal ideation or behavior in patients taking bimekizumab?
Featuring April Armstrong, MD, MPH | Co-Director |
Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA
Related CME
Related Media
Powered by Polaris TM